Literature DB >> 31447305

Improving the cascade of global tuberculosis care: moving from the "what" to the "how" of quality improvement.

Bruce D Agins1, Daniel J Ikeda2, Michael J A Reid3, Eric Goosby3, Madhukar Pai4, Adithya Cattamanchi5.   

Abstract

Tuberculosis is preventable, treatable, and curable, yet it has the highest mortality rate of infectious diseases worldwide. Over the past decade, services to prevent, screen, diagnose, and treat tuberculosis have been developed and scaled up globally, but progress to end the disease as a public health threat has been slow, particularly in low-income and middle-income countries. In these settings, low-quality tuberculosis prevention, diagnostic, and treatment services frustrate efforts to translate use of existing tools, approaches, and treatment regimens into improved individual and public health outcomes. Increasingly sophisticated methods have been used to identify gaps in quality of tuberculosis care, but inadequate work has been done to apply these findings to activities that generate population-level improvements. In this Personal View, we contend that shifting the focus from the "what" to the "how" of quality improvement will require National Tuberculosis Programmes to change the way they organise, use data, implement, and respond to the needs and preferences of people with tuberculosis and at-risk communities.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31447305     DOI: 10.1016/S1473-3099(19)30420-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  12 in total

Review 1.  Yield and Coverage of Active Case Finding Interventions for Tuberculosis Control:A Systematic Review and Meta-analysis.

Authors:  Ruth W Deya; Linnet N Masese; Walter Jaoko; Jeremiah Chakaya Muhwa; Lilian Mbugua; David J Horne; Susan M Graham
Journal:  Tuberc Res Treat       Date:  2022-06-30

Review 2.  Closing gaps in the tuberculosis care cascade: an action-oriented research agenda.

Authors:  Ramnath Subbaraman; Tulip Jhaveri; Ruvandhi R Nathavitharana
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-01-11

3.  Progress toward Developing Sensitive Non-Sputum-Based Tuberculosis Diagnostic Tests: the Promise of Urine Cell-Free DNA.

Authors:  Emily MacLean; Ruvandhi R Nathavitharana
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

Review 4.  Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease.

Authors:  David J Sherman; Jing Li
Journal:  Molecules       Date:  2020-02-05       Impact factor: 4.411

5.  Tuberculosis Scientific Conferences in Peru: Sharing local evidence for local decisions.

Authors:  Alvaro Schwalb; Rodrigo Cachay; Maricela Curisinche-Rojas; Eduardo Gotuzzo; Julia Ríos; César Ugarte-Gil
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-03-26

6.  Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR.

Authors:  Prem Perumal; Mohamed Bilal Abdullatif; Harriet N Garlant; Isobella Honeyborne; Marc Lipman; Timothy D McHugh; Jo Southern; Ronan Breen; George Santis; Kalaiarasan Ellappan; Saka Vinod Kumar; Harish Belgode; Ibrahim Abubakar; Sanjeev Sinha; Seshadri S Vasan; Noyal Joseph; Karen E Kempsell
Journal:  Front Immunol       Date:  2021-03-16       Impact factor: 7.561

7.  Prediagnostic loss to follow-up in an active case finding tuberculosis programme: a mixed-methods study from rural Bihar, India.

Authors:  Tushar Garg; Vivek Gupta; Dyuti Sen; Madhur Verma; Miranda Brouwer; Rajeshwar Mishra; Manish Bhardwaj
Journal:  BMJ Open       Date:  2020-05-15       Impact factor: 2.692

8.  Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.

Authors:  Tsegahun Manyazewal; Yimtubezinash Woldeamanuel; David P Holland; Abebaw Fekadu; Henry M Blumberg; Vincent C Marconi
Journal:  Trials       Date:  2020-05-05       Impact factor: 2.279

9.  Chest Radiography and Xpert MTB/RIF® Testing in Persons with Presumptive Pulmonary TB: Gaps and Challenges from a District in Karnataka, India.

Authors:  Manjula Kanakaraju; Sharath Burugina Nagaraja; Srinath Satyanarayana; Yella Ramesh Babu; Akshaya Kibballi Madhukeshwar; Somashekar Narasimhaiah
Journal:  Tuberc Res Treat       Date:  2020-01-04

Review 10.  Establishing the cascade of care for patients with tuberculous meningitis.

Authors:  Darma Imran; Philip C Hill; Jacob McKnight; Reinout van Crevel
Journal:  Wellcome Open Res       Date:  2019-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.